Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIACTA in AA Amyloidosis
NCT01215747Phase 3Completed
- Sponsor
- C.T. Development America
- Start
- Nov 2010
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of eprodisate in AA amyloidosis, sponsored by C.T. Development America. Started Nov 2010; status: completed.
02
Drugs
eprodisate
03
Conditions
AA amyloidosis
Beyond the preview
Go deeper on NCT01215747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215747.